Thanks for the reminder. I agree with your comment. As for Schroe's earlier comment, he is correct, but I have the conviction that the payoff will come much sooner. All of the preparation for launch is likely window dressing/insurance and is not a definitive indicator of a desire to go it alone. Among other things, Prabtha is 67 and I imagine would just as soon cash out upon regulatory approval.
Pardon me, but if that is the way you analyze the situation (and you have proffered no analysis, just conclusions), by all means sell and leave this board. Prabtha is perfectly teeing CEMP for a sale at a high price.
Prabtha is doing excalty what a great CEO would do: she is setting the table for a buyout or a going it alone approach. The two alternatives dictate the same strategy. The worst situation would be if CEMP sat on its hands waiting for a low ball offer from Merck or other big pharma based solely on clinical results. Acquisition alternative can be facilitated by all the strategizing and implementation that has been undertaken pre acquisition. If acquisition does not occur, CEMP proceeds eyes wide open. Win win Prabtha and her team are par excellence. She can't and won't tell us all that is going through her and the team's collective minds.
I hear the conclusion. What is the analysis? Your conclusion that CEMP will go it alone is a 50/50 bet at best.
Yes, but she is a poker player, and wisely so. We all want the best price. She must prepare for the eventuality that acquisition is not achieved before or immediately after FDA and EU approval. Furthermore, serous preparation for commercialization strengthens her hand in negotiating good terms for the sale; it makes credible the assertion that the company is prepared to go it alone. I have great confidence that Prabtha and the board have their fiduciary responsibilities to the shareholders foremost in their minds.
Either way she is proceeding appropriately and in a timely fashion, contrary to the assertions of some posters.
Takes fewer than 15 minutes to be efficacious. Do your due diligence. If it didn't, US military wouldn't have spent millions of dollars on the trials.
No dilution till sales occur. Don't believe company has sol shares yet. This was just a shelf filing.
But it isn't an hour with sufentanil. Can't you read English? Your facts aren't facts. Do your due diligence, for crying out loud! Or just read some posts and try to comprehend if you can that your facts are in error.